Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China
- PMID:19574785
- DOI: 10.1111/IGC.0b013e3181a58fef
Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China
Abstract
Introduction: Human papillomavirus (HPV) is the main etiologic factor for cervical cancer (CC). To investigate the prevalence of HPV types in archival CC and its precursors collected form Tongliao area, which is located in the east of Inner Mongolian autonomous region, China, and compare the genotype distribution of HPV in cervical lesions between Han Chinese and Mongolian.
Methods: The infections of HPV in a total of 175 cases of formalin-fixed, paraffin-embedded samples, including 71 low-grade squamous intraepithelial lesions (LSIL), 27 high-grade squamous intraepithelial lesions (HSIL), and 77 CC were detected by the combination of consensus primers nested polymerase chain reaction (PCR) and type-specific primers nested PCR.
Results: Overall, HPV prevalence was 93.5% in CC, 92.6% in HSIL, and 63.4% in LSIL. Human papillomavirus 16 was the most predominant HPV type in all cervical lesions, detected in 83.1% of CC, 77.8% of HSIL, and 33.8% of LSIL. Human papillomavirus 45 was the second most predominant HPV type in CC (16.9%) and HSIL (11.1%). Human papillomavirus 33 was the second most predominant HPV type in LSIL (8.5%). Human papillomavirus 18, equal with HPV 45, was the second most common type in Mongolian CC (15.6%), whereas in Han Chinese specimens, no HPV 18 was found.
Conclusions: The prevalence of HPV 45 in CC and HSIL in Tongliao area were relatively higher than other regions of China. Comparing the distribution of HPV types in Han Chinese and Mongolian, the prevalence of HPV 18 in CC from Mongolian was significantly higher than that in Han Chinese.
Similar articles
- Characterization of human papillomavirus genotypes infections in patients with cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.Wang Y, Maisaidi R, Zhang S, Reheman Y, Han L.Wang Y, et al.Virol J. 2025 Mar 13;22(1):72. doi: 10.1186/s12985-025-02674-1.Virol J. 2025.PMID:40082961Free PMC article.
- Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD.Castle PE, et al.Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):946-53. doi: 10.1158/1055-9965.EPI-10-1267. Epub 2011 Mar 17.Cancer Epidemiol Biomarkers Prev. 2011.PMID:21415357Free PMC article.Clinical Trial.
- Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X.Berois N, et al.Int J Gynecol Cancer. 2013 Mar;23(3):527-32. doi: 10.1097/IGC.0b013e318285e753.Int J Gynecol Cancer. 2013.PMID:23392403
- Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.Futai M, Watanabe J, Jobo T, Tsunoda S, Nishimura Y, Watanabe K, Okayasu I, Unno N.Futai M, et al.Int J Gynecol Cancer. 2009 Nov;19(8):1396-401. doi: 10.1111/IGC.0b013e3181b661a4.Int J Gynecol Cancer. 2009.PMID:20009896
- Clinical and molecular classification of vulvar squamous pre-cancers.Cohen PA, Anderson L, Eva L, Scurry J.Cohen PA, et al.Int J Gynecol Cancer. 2019 May;29(4):821-828. doi: 10.1136/ijgc-2018-000135. Epub 2019 Feb 7.Int J Gynecol Cancer. 2019.PMID:30737358Review.
Cited by
- Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.Xiao M, et al.Medicine (Baltimore). 2016 Jan;95(3):e2555. doi: 10.1097/MD.0000000000002555.Medicine (Baltimore). 2016.PMID:26817906Free PMC article.
- Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.Xu HH, Wang K, Feng XJ, Dong SS, Lin A, Zheng LZ, Yan WH.Xu HH, et al.Oncotarget. 2018 Jan 11;9(20):15386-15397. doi: 10.18632/oncotarget.24169. eCollection 2018 Mar 16.Oncotarget. 2018.PMID:29632652Free PMC article.
- The development of simultaneous measurement of viral load and physical status for human papillomavirus 16 and 18 co-infection using multiplex quantitative polymerase chain reaction.Prasongdee P, Tippayawat P, Limpaiboon T, Leelayuwat C, Wongwattanakul M, Jearanaikoon P.Prasongdee P, et al.Oncol Lett. 2018 Dec;16(6):6977-6987. doi: 10.3892/ol.2018.9549. Epub 2018 Oct 4.Oncol Lett. 2018.PMID:30546431Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical